Policy analysis and advocacy decision model for HIV-related services: People who inject drugs

In collaboration with the Eurasian Harm Reduction Network (EHRN), HPP has designed a policy decision model focused on persons who inject drugs (PWID). The PWID decision model identifies the existence of restrictive, poorly written, or absent enabling policies that may serve as obstacles for programs to provide both sustained and accessible HIV counseling and testing, antiretroviral therapy, hepatitis, tuberculosis, opioid substitution therapy, and sterile needle and syringe program services for PWID. It is also inclusive of issues such as stigma and discrimination, gender-based violence, and criminal justice systems.

While designed for global adaptation and application, the decision model specifically addresses policy barriers common in Eastern Europe.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.